S 5226 · 118th Congress · Health

Sickle Cell Disease Treatment Centers Act of 2024

Introduced 2024-09-25· Sponsored by Sen. Van Hollen, Chris [D-MD]· Senate

Bill Progress

Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2024-09-25)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [S. 5226 Introduced in Senate (IS)] <DOC> 118th CONGRESS 2d Session S. 5226 To establish a program to address sickle cell disease and other heritable hemoglobinopathies. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES September 25, 2024 Mr. Van Hollen (for himself and Mr. Booker) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To establish a program to address sickle cell disease and other heritable hemoglobinopathies. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Sickle Cell Disease Treatment Centers Act of 2024''. SEC. 2. ESTABLISHMENT OF SICKLE CELL DISEASE AND OTHER HERITABLE HEMOGLOBINOPATHIES TREATMENT CENTERS. Subpart I of part D of title III of the Public Health Service Act (42 U.S.C. 254b et seq.) is amended by inserting after section 330P (42 U.S.C. 254c-22…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (2)

2 Democrats